Locations:
Search IconSearch
September 21, 2023/Cancer/Radiation Oncology

Top 10 Presentations You Don’t Want to Miss at ASTRO 2023

Highlighting top abstracts for the annual radiation oncology conference

23-CNR-4164208 ASTRO 2023 graphic CQD

The field of radiation therapy has evolved in recent years due to advances in technology and techniques. To stay ahead, radiation oncologists converge each year at the ASTRO (American Society of Radiation Oncology) annual meeting to glean the latest scientific research. To help prepare for the upcoming 2023 meeting, radiation oncology leaders from Cleveland Clinic’s Cancer Center have highlighted ten of the top abstracts of note to watch for.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Patient-Free Simulation: Analysis of Hospitalized Patients Treated without CT Simulation
Presented by Erik Davies, MD
Abstract #2215
10:45am-12:00PM PT, Monday, October 2
Hall B2

Phase II Randomized Trial of Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases
Presented by Cole Billena, MD
Abstract #2917
10:45AM-12:00PM PT, Monday, October 2
Hall B2

Five Fraction Accelerated Partial Breast Irradiation vs. Intraoperative Radiation Therapy for Early-Stage Breast Cancer
Presented by Ahmed Hamila, MD
Abstract #2377
3:00-4:00PM PT, Monday, October 2
Hall B2

Impact on Radiation Therapy Recommendation and Treatment Modality for Patients With Ductal Carcinoma In Situ Using the 7Gene Biosignature: Analysis of the PREDICT Study
Presented by Chirag Shah, MD
Abstract #2439
3:00-4:00PM PT, Tuesday, October 3
Hall B2

Results of a Phase I Trial of Dose Escalation for Preoperative Stereotactic Radiosurgery for Patients with Large Brain Metastases
Presented by Kailin Yang, MD, PhD
Abstract #243
2:33-2:40PM PT, Tuesday, October 3
Room 6 C/F

Local Cost-Effectiveness of Nasopharyngeal Carcinoma Screening Strategies in Southern China: Secondary Analysis of the PRO-NPC-001 Cluster-Randomized Trial
Presented by Jacob Miller, MD
Abstract #234
3:00-3:07PM PT, Tuesday, October 3
Room 1

Sema3C Signaling is an Alternative Activator of the Canonical WNT Pathway in Glioblastoma
Presented by Jennifer Yu, MD, PhD
Abstract #1120
4:05-4:10PM PT, Tuesday, October 3
Room 8

Advertisement

Meta-Analysis of Five Fraction Preoperative Radiotherapy for Soft Tissue Sarcoma
Presented by Zachary Mayo, MD
Abstract #1156
4:05-4:10PM PT, Tuesday, October 3
Room 5

Liver Dome Gating Using kV Triggered Imaging Reduces Dosimetric Error Caused by Breath Hold Variability for Liver Stereotactic Body Radiation Therapy
Presented by Bingqi Guo, PhD
Abstract #1288
8:30-8:35AM PT, Tuesday, October 3
Room 8

Can We Improve the Quality of Care Delivered to Cervical Cancer Patients? Development of Quality Metrics and Quality Improvement Program at a Single Institution
Presented by Sudha Amarnath, MD
Abstract #292
11:20-11:27AM PT, Wednesday, October 4
Room 2

Advertisement

Related Articles

Doctors working on MGUS screening study
March 18, 2024/Cancer/Research
Pilot Study Aims for Early Identification of Multiple Myeloma Precursor Among Black Patients

First-of-its-kind research investigates the viability of standard screening to reduce the burden of late-stage cancer diagnoses

Hematologist at Cleveland Clinic
March 14, 2024/Cancer/Blood Cancers
Advances in Mantle Cell Lymphoma Treatment (Podcast)

Global R&D efforts expanding first-line and relapse therapy options for patients

Physician with patient
March 6, 2024/Cancer/Research
Targeting Uncontrolled Erythrocytosis in Polycythemia Vera with Rusfertide

Study demonstrates ability to reduce patients’ reliance on phlebotomies to stabilize hematocrit levels

Dr. Jagadeesh at Cleveland Clinic
February 28, 2024/Cancer/Blood Cancers
Treating Patient with Systemic T-Cell Lymphoma and Graft-Versus-Host Disease

A case study on the value of access to novel therapies through clinical trials

Doctor measuring patient's waist size
February 26, 2024/Cancer/Research
Impact of Obesity on GVHD & Transplant Outcomes in Hematologic Malignancies

Findings highlight an association between obesity and an increased incidence of moderate-severe disease

Physician with patient
February 21, 2024/Cancer/Research
Strategies for Improving Clinical Trial Equity

Cleveland Clinic Cancer Institute takes multi-faceted approach to increasing clinical trial access 23456

How antibody drug conjugates work
February 13, 2024/Cancer/Research
Real-World Use of Trastuzumab Deruxtecan

Key learnings from DESTINY trials

CQD-4445459-rotz-650×450
February 7, 2024/Cancer
Advances in Bone Marrow Transplant Have Improved Outcomes in Fanconi Anemia

Overall survival in patients treated since 2008 is nearly 20% higher than in earlier patients

Ad